Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses

Open Access

Peer-reviewed

Research Article

Stuart D. Dowall ,

* E-mail: stuart.dowall@phe.gov.uk

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Victoria A. Graham,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Emma Rayner,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Laura Hunter,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Robert Watson,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Irene Taylor,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Antony Rule,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Miles W. Carroll,

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯
Roger Hewson

Affiliation Public Health England, Porton Down, Salisbury, Wiltshire, United Kingdom
⨯

Reader Comments (0)

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Crimean-Congo hemorrhagic fever
Is the Subject Area "Crimean-Congo hemorrhagic fever" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.